3🦠y la inmunidad q confirieron los coronavirus q causan MERS y SARS dieron protección para reinfecciones de 3 y 2 años respectivamente. ➡️Hoy es importante seguir revisando la calidad, cantidad y duración de la inmunidad luego de infección con SARSCoV2 2/h
RT @aharrasi1: 10/18 اذا عند مقارنة فيروس كورونا المستجد بفيروسات مشابهة مثل سارس وميرس فان الأبحاث أثبتت بقاء المناعة من هذه الفيروسات لمد…
RT @aharrasi1: 10/18 اذا عند مقارنة فيروس كورونا المستجد بفيروسات مشابهة مثل سارس وميرس فان الأبحاث أثبتت بقاء المناعة من هذه الفيروسات لمد…
RT @aharrasi1: 10/18 اذا عند مقارنة فيروس كورونا المستجد بفيروسات مشابهة مثل سارس وميرس فان الأبحاث أثبتت بقاء المناعة من هذه الفيروسات لمد…
RT @aharrasi1: 10/18 اذا عند مقارنة فيروس كورونا المستجد بفيروسات مشابهة مثل سارس وميرس فان الأبحاث أثبتت بقاء المناعة من هذه الفيروسات لمد…
RT @aharrasi1: 10/18 اذا عند مقارنة فيروس كورونا المستجد بفيروسات مشابهة مثل سارس وميرس فان الأبحاث أثبتت بقاء المناعة من هذه الفيروسات لمد…
10/18 اذا عند مقارنة فيروس كورونا المستجد بفيروسات مشابهة مثل سارس وميرس فان الأبحاث أثبتت بقاء المناعة من هذه الفيروسات لمدة سنتين. هنا الأبحاث السابقة على هذه الفيروسات: https://t.co/MLZo1M5VLl https://t.co/m0WC8YO3bi https://t.co/qEKv1DwwDW https://t.co
en un mes, 6 meses, 1 año? Saber eso es incierto. Recién conocemos al virus, así que estimar la duración de anticuerpos es una incógnita. En otras infecciones coronavirales, la respuesta suele durar 6 meses o algo más, pero ¿será igual para el #SARSCoV2?
From one the studies Crotty cites 'Antibody titers in 4 of 6 patients who had mild illness were undetectable even though most had evidence of pneumonia.' https://t.co/dnzYXyhHI4
RT @jplotkin: @jbloom_lab See also related relevant data here: https://t.co/TcxKUU1r1x
RT @jplotkin: @jbloom_lab See also related relevant data here: https://t.co/TcxKUU1r1x
RT @jplotkin: @BallouxFrancois @jeremyvancleve The only longitudinal study I've seen shows broadly stable antibody titers for at least a ye…
RT @jplotkin: @BallouxFrancois @jeremyvancleve The only longitudinal study I've seen shows broadly stable antibody titers for at least a ye…
RT @jplotkin: @BallouxFrancois @jeremyvancleve The only longitudinal study I've seen shows broadly stable antibody titers for at least a ye…
RT @jplotkin: @jbloom_lab See also related relevant data here: https://t.co/TcxKUU1r1x
@jbloom_lab See also related relevant data here: https://t.co/TcxKUU1r1x
@MartinRemains @BallouxFrancois Whereas studies on a single coronavirus show long-lived antibodies. https://t.co/sU9MnGc67r
RT @jplotkin: @BallouxFrancois @jeremyvancleve The only longitudinal study I've seen shows broadly stable antibody titers for at least a ye…
@BallouxFrancois @jeremyvancleve The only longitudinal study I've seen shows broadly stable antibody titers for at least a year, among n=11 patients who recovered from MERS-CoV. https://t.co/2uSPaN6Dor https://t.co/EmjTLP4ujo
RT @ngranati: @DrMattMcCarthy @AndurandPierre The simple answer is we don't know but there is peer-review research on MERS where patients d…
RT @ngranati: @DrMattMcCarthy @AndurandPierre The simple answer is we don't know but there is peer-review research on MERS where patients d…
@DrMattMcCarthy @AndurandPierre The simple answer is we don't know but there is peer-review research on MERS where patients don't show lasting immunity https://t.co/7qQdn4tn0j
RT @Reebola95: MERS-CoV Antibody Responses 1 Year after Symptom Onset "..robust serologic antibody titers did not develop during the acute…
MERS-CoV Antibody Responses 1 Year after Symptom Onset "..robust serologic antibody titers did not develop during the acute phase of the illness, and the patients remained seronegative or with marginal antibody titers at 1 year after infection." https://t
@azeem @Peston @tomstandage @medrxivpreprint @RanuDhillon @CMO_England @AdamJKucharski @lancet @trvrb We also know from another coronavirus MERS that patient don't necessarily have lasting immunisation from a paper from 2017 looking at a sample of 6 patien
@kiwispillow @JuddLegum They would need to work quickly. In MERS, “Antibody titers in 4 of 6 patients who had mild illness were undetectable even though most had evidence of pneumonia.” Apparently people with mild symptoms didn’t retain antibodies for lon
@Thushan_deSilva @Anwar_Hashem Here are some more refs for SARS/MERS: https://t.co/o4cFTKpL0T https://t.co/0t0ZN2iA0J
@CvandeSandt @Crof @kedzierskalab @MarionKoopmans Here are some more refs for SARS/MERS: https://t.co/h9Fiff5EPP https://t.co/XJmS6g0jw7
#KSVirus Malik Peiris note that level of antibody response is higher in severe ill, some even barely mount an antibody response. https://t.co/rqz1KlrM3I so mild infections would be missed
#MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea. Emerging Infectious Disease journal - CDC https://t.co/00tmTv4Btq
RT @MERS_inSAUDI: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. https://t.co/UavtnDITJa
RT @MERS_inSAUDI: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. https://t.co/UavtnDITJa
RT @MERS_inSAUDI: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. https://t.co/UavtnDITJa
RT @MERS_inSAUDI: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. https://t.co/UavtnDITJa
RT @MERS_inSAUDI: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. https://t.co/UavtnDITJa
RT @InfectiousDz: Likely,"MERS-CoV seroepidemiologic studies markedly underestimate the extent of mild and asymptomatic infection" https://…
Likely,"MERS-CoV seroepidemiologic studies markedly underestimate the extent of mild and asymptomatic infection" https://t.co/aY7aAeNW1u
RT @greg_folkers: EID journal: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 https://t.co/s45OdvB6I0 https://…
EID journal: #MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 https://t.co/s45OdvB6I0 https://t.co/pIIy8fnSef
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 | https://t.co/833LRpSnCF via @CDCgov
"Serologic responses to MERS-CoV is variable, not robust, and often undetectable when disease is mild." #Coronavirus https://t.co/osjEnHCXT0
MERS-Coronavirus antibody responses one year after symptom onset: https://t.co/BTYY5eE51H via @CDC_EIDjournal